Delivery Order SPE2DB20D3101-SPE2DB25FRKV4
Award Date
5/20/25
Potential Completion Date
5/21/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 capsules of 15 milligram dextroamphetamine-amphetamine, a medication used to treat attention deficit hyperactivity disorder (ADHD). The contract has a ceiling value of $2,251.46 and a completion date of May 22, 2025. This award is not a set-aside and is part of...
This federal contract award is a delivery order worth $2,286.60 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) and is for the delivery of 20mg dextroamphetamine-amphetamine capsules. The contract is a firm fixed-price delivery order with a completion date of May 13, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,212.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Dextroamphetamine-Amphetamine ER 25 mg Capsules, a medication commonly used to treat conditions like ADHD. The award has an ultimate completion date of March 6, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,873,962 milliliters of dextroamphetamine 5 milligrams per 5 milliliters, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm-fixed-price, non-set-aside delivery order with a ceiling value of $3,379.93 and a performance period...
This federal contract award is for the delivery of 10 mg tablets of the medication dextroamphetamine-amphetamine, with a ceiling value of $4,099.20. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 10 mg dextroamphetamine tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD) and other conditions. The contract has a ceiling value of $2,106.69 and a period of performance through March 27, 2023. This contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20 mg capsules of the drug dextroamphetamine-amphetamine, a treatment for conditions such as attention-deficit/hyperactivity disorder (ADHD). The fixed-price contract has a ceiling value of $9,681.61 and a completion date of May 21, 2025. The contract is not set aside for...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,379.38 firm-fixed-price contract is for the delivery of 4,566,357,650 units of 5 mg dextroamphetamine-amphetamine tablets, which will be completed by November 7, 2024. The award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a $3,252.27 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for Dextroamphetamine-Amphetamine ER 20 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The order has a completion date of May 13, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of...
This federal contract award, valued at $1,038.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...